| A Cell Specific Effect of MBOAT7 MAFLD-risk Variant on Immune Cells. | A Cell Specific Effect of MBOAT7 MAFLD-risk Variant on Immune Cells.
Pan Z, Alharthi J, Bayoumi A, George J, Eslam M. | 05/23/2024 |
| Membrane-bound O-acyltransferase 7 (MBOAT7) shapes lysosomal lipid homeostasis and function to control alcohol-associated liver injury. | Membrane-bound O-acyltransferase 7 (MBOAT7) shapes lysosomal lipid homeostasis and function to control alcohol-associated liver injury.
Varadharajan V, Ramachandiran I, Massey WJ, Jain R, Banerjee R, Horak AJ, McMullen MR, Huang E, Bellar A, Lorkowski SW, Gulshan K, Helsley RN, James I, Pathak V, Dasarathy J, Welch N, Dasarathy S, Streem D, Reizes O, Allende DS, Smith JD, Simcox J, Nagy LE, Brown JM., Free PMC Article | 04/30/2024 |
| Exome sequencing identifies homozygous variants in MBOAT7 associated with neurodevelopmental disorder. | Exome sequencing identifies homozygous variants in MBOAT7 associated with neurodevelopmental disorder.
Nazmina G, Khan A, Jiang J, Miao Z, Khan SN, Khan MI, Shah AH, Shah AH, Khisroon M, Haack TB. | 03/7/2024 |
| MBOAT7 rs641738 Variant Is Not Associated with an Increased Risk of Hepatocellular Carcinoma in a Latin American Cohort. | MBOAT7 rs641738 Variant Is Not Associated with an Increased Risk of Hepatocellular Carcinoma in a Latin American Cohort.
Goble S, Akambase J, Prieto J, Balderramo D, Ferrer JD, Mattos AZ, Arrese M, Carrera E, Groothuismink ZMA, Oliveira J, Boonstra A, Debes JD., Free PMC Article | 02/6/2024 |
| MBOAT7 expression is associated with disease progression in COVID-19 patients. | MBOAT7 expression is associated with disease progression in COVID-19 patients.
Radwan E, Abdelaziz A, Mandour MAM, Meki AMA, El-Kholy MM, Mohamed MN., Free PMC Article | 01/10/2024 |
| MBOAT7 in liver and extrahepatic diseases. | MBOAT7 in liver and extrahepatic diseases.
Caddeo A, Spagnuolo R, Maurotti S. | 10/30/2023 |
| MMD collaborates with ACSL4 and MBOAT7 to promote polyunsaturated phosphatidylinositol remodeling and susceptibility to ferroptosis. | MMD collaborates with ACSL4 and MBOAT7 to promote polyunsaturated phosphatidylinositol remodeling and susceptibility to ferroptosis.
Phadnis VV, Snider J, Varadharajan V, Ramachandiran I, Deik AA, Lai ZW, Kunchok T, Eaton EN, Sebastiany C, Lyakisheva A, Vaccaro KD, Allen J, Yao Z, Wong V, Geng B, Weiskopf K, Clish CB, Brown JM, Stagljar I, Weinberg RA, Henry WS., Free PMC Article | 10/11/2023 |
| Effects of MBOAT7 polymorphism and steatosis on liver function assessed by methacetin breath test. | Effects of MBOAT7 polymorphism and steatosis on liver function assessed by methacetin breath test.
Di Ciaula A, Bonfrate L, Shanmugam H, Weber SN, Krawczyk M, Portincasa P. | 07/31/2023 |
| MBOAT7 rs641738 (C>T) is associated with NAFLD progression in men and decreased ASCVD risk in elder Chinese population. | MBOAT7 rs641738 (C>T) is associated with NAFLD progression in men and decreased ASCVD risk in elder Chinese population.
Xu X, Xu H, Liu X, Zhang S, Cao Z, Qiu L, Du X, Liu Y, Wang G, Zhang L, Zhang Y, Zhang J., Free PMC Article | 07/12/2023 |
| A metabolic associated fatty liver disease risk variant in MBOAT7 regulates toll like receptor induced outcomes. | A metabolic associated fatty liver disease risk variant in MBOAT7 regulates toll like receptor induced outcomes.
Alharthi J, Bayoumi A, Thabet K, Pan Z, Gloss BS, Latchoumanin O, Lundberg M, Twine NA, McLeod D, Alenizi S, Adams LA, Weltman M, Berg T, Liddle C, George J, Eslam M., Free PMC Article | 12/17/2022 |
| Membrane-bound O-acyltransferase 7 (MBOAT7)-driven phosphatidylinositol remodeling in advanced liver disease. | Membrane-bound O-acyltransferase 7 (MBOAT7)-driven phosphatidylinositol remodeling in advanced liver disease.
Varadharajan V, Massey WJ, Brown JM., Free PMC Article | 07/30/2022 |
| Expression of Membrane Bound O-Acyltransferase Domain Containing 7 after Myocardial Infarction and its Role in Lipid Metabolism in vitro. | Expression of Membrane Bound O-Acyltransferase Domain Containing 7 after Myocardial Infarction and its Role in Lipid Metabolism in vitro.
Li X, Wang Z, Meng H, Meng F, Yang P., Free PMC Article | 05/28/2022 |
| TM6SF2/PNPLA3/MBOAT7 Loss-of-Function Genetic Variants Impact on NAFLD Development and Progression Both in Patients and in In Vitro Models. | TM6SF2/PNPLA3/MBOAT7 Loss-of-Function Genetic Variants Impact on NAFLD Development and Progression Both in Patients and in In Vitro Models.
Longo M, Meroni M, Paolini E, Erconi V, Carli F, Fortunato F, Ronchi D, Piciotti R, Sabatini S, Macchi C, Alisi A, Miele L, Soardo G, Comi GP, Valenti L, Ruscica M, Fracanzani AL, Gastaldelli A, Dongiovanni P., Free PMC Article | 04/16/2022 |
| Loss of hepatic Mboat7 leads to liver fibrosis. | Loss of hepatic Mboat7 leads to liver fibrosis.
Thangapandi VR, Knittelfelder O, Brosch M, Patsenker E, Vvedenskaya O, Buch S, Hinz S, Hendricks A, Nati M, Herrmann A, Rekhade DR, Berg T, Matz-Soja M, Huse K, Klipp E, Pauling JK, Wodke JA, Miranda Ackerman J, Bonin MV, Aigner E, Datz C, von Schönfels W, Nehring S, Zeissig S, Röcken C, Dahl A, Chavakis T, Stickel F, Shevchenko A, Schafmayer C, Hampe J, Subramanian P., Free PMC Article | 12/4/2021 |
| The MBOAT7 rs641738 variant is associated with an improved outcome in primary sclerosing cholangitis. | The MBOAT7 rs641738 variant is associated with an improved outcome in primary sclerosing cholangitis.
Freund C, Wahlers A, Begli NH, Leopold Y, Klöters-Plachky P, Mehrabi A, Mohr I, Sander J, Rupp C, Gotthardt DN, Weiss KH. | 11/6/2021 |
| Identification of novel loss of function variants in MBOAT7 resulting in intellectual disability. | Identification of novel loss of function variants in MBOAT7 resulting in intellectual disability.
Heidari E, Caddeo A, Zarabadi K, Masoudi M, Tavasoli AR, Romeo S, Garshasbi M. | 09/18/2021 |
| Association Between a Polymorphism in MBOAT7 and Chronic Kidney Disease in Patients With Biopsy-Confirmed Nonalcoholic Fatty Liver Disease. | Association Between a Polymorphism in MBOAT7 and Chronic Kidney Disease in Patients With Biopsy-Confirmed Nonalcoholic Fatty Liver Disease.
Koo BK, An JN, Joo SK, Kim D, Lee S, Bae JM, Park JH, Kim JH, Chang MS, Kim W. | 09/18/2021 |
| Genetic predisposition in metabolic-dysfunction-associated fatty liver disease and cardiovascular outcomes-Systematic review. | Genetic predisposition in metabolic-dysfunction-associated fatty liver disease and cardiovascular outcomes-Systematic review.
Ismaiel A, Dumitrascu DL. | 09/11/2021 |
| LPIAT1/MBOAT7 contains a catalytic dyad transferring polyunsaturated fatty acids to lysophosphatidylinositol. | LPIAT1/MBOAT7 contains a catalytic dyad transferring polyunsaturated fatty acids to lysophosphatidylinositol.
Caddeo A, Hedfalk K, Romeo S, Pingitore P. | 07/3/2021 |
| A patient with novel MBOAT7 variant: The cerebellar atrophy is progressive and displays a peculiar neurometabolic profile. | A patient with novel MBOAT7 variant: The cerebellar atrophy is progressive and displays a peculiar neurometabolic profile.
Farnè M, Tedesco GM, Bedetti C, Mencarelli A, Rogaia D, Colavito D, Di Cara G, Stangoni G, Troiani S, Ferlini A, Prontera P. | 06/5/2021 |
| Association between MBOAT7 rs641738 polymorphism and non-alcoholic fatty liver in overweight or obese children. | Association between MBOAT7 rs641738 polymorphism and non-alcoholic fatty liver in overweight or obese children.
Zusi C, Morandi A, Maguolo A, Corradi M, Costantini S, Mosca A, Crudele A, Mantovani A, Alisi A, Miraglia Del Giudice E, Targher G, Maffeis C. | 05/29/2021 |
| MBOAT7 down-regulation by genetic and environmental factors predisposes to MAFLD. | MBOAT7 down-regulation by genetic and environmental factors predisposes to MAFLD.
Meroni M, Longo M, Fracanzani AL, Dongiovanni P., Free PMC Article | 05/29/2021 |
| MBOAT7-driven phosphatidylinositol remodeling promotes the progression of clear cell renal carcinoma. | MBOAT7-driven phosphatidylinositol remodeling promotes the progression of clear cell renal carcinoma.
Neumann CKA, Silver DJ, Venkateshwari V, Zhang R, Traughber CA, Przybycin C, Bayik D, Smith JD, Lathia JD, Rini BI, Brown JM., Free PMC Article | 02/27/2021 |
| Genetic Susceptibility to Chronic Liver Disease in Individuals from Pakistan. | Genetic Susceptibility to Chronic Liver Disease in Individuals from Pakistan.
Raja AM, Ciociola E, Ahmad IN, Dar FS, Naqvi SMS, Moaeen-Ud-Din M, Kaukab Raja G, Romeo S, Mancina RM., Free PMC Article | 02/27/2021 |
| Metabolic syndrome but not genetic polymorphisms known to induce NAFLD predicts increased total mortality in subjects with NAFLD (OPERA study). | Metabolic syndrome but not genetic polymorphisms known to induce NAFLD predicts increased total mortality in subjects with NAFLD (OPERA study).
Käräjämäki AJ, Hukkanen J, Kauma H, Kesäniemi YA, Ukkola O. | 02/20/2021 |